top of page
Impact Logo

Caring. Convenient. Consistent. Committed.

Medication Information

SEMAGLUTIDE & TIRZEPATIDE WEIGHT LOSS INFORMATION

SEMAGLUTIDE INFORMATION (GLP-1)

​

Semaglutide is the active ingredient in the medications Wegovy® and Ozempic®.  

  • Semaglutide is compounded with Vitamin B6 which helps alleviate side effects

  • Injections are once weekly and are delivered to your home after being approved by one of our medical partners.

 

WEIGHT LOSS BENEFITS​

  • Improved appetite regulation

  • Delayed gastric emptying leading to prolonged sense of fullness

  • Enhanced glucose-dependent insulin secretion boosting the release of insulin around elevated blood glucose levels

  • Glucagon suppression creating better glycemic control

  • An increase in energy expenditure and fat burning that causes positive changes to cholesterol and triglyceride levels

  • Expected weight loss of 1-2 pounds/week

  • Clinical trials have shown up to 15-20% of one's body weight.

 

COMMON SIDE EFFECTS

  • Nausea

  • Constipation

  • Indigestion

  • Diarrhea

​

RISK OF THYROID C-CELL TUMORS

If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take semaglutide

 

TIRZEPATIDE INFORMATION (GLP-1 + GIP)

 

Tirzepatide is the active ingredient in the medications Mounjaro® and Zepbound®.

  • Tirzepatide is compounded with Vitamin B6 helps alleviate side effects

  • Injections are once weekly and are delivered to your home after being approved by one of our medical partners.

 

WEIGHT LOSS BENEFITS

  • Improved appetite regulation

  • Delayed gastric emptying leading to prolonged sense of fullness

  • Enhanced glucose-dependent insulin secretion boosting the release of insulin around elevated blood glucose levels

  • Glucagon suppression creating better glycemic control

  • An increase in energy expenditure and fat burning that causes positive changes to cholesterol and triglyceride levels

  • Added GIP receptor agonist

    • increased fullness​

    • decreased gastric secretion

    • increased insulin secretion

    • increased fat breakdown (lipolysis)

  • Expected weight loss of 1-2 pounds/week

  • Clinical trials showed 15% to 30% weight loss depending on dose

 

COMMON SIDE EFFECTS

  • Nausea

  • Constipation

  • Indigestion

  • Diarrhea

 

RISK OF THYROID C-CELL TUMORS

  • If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take tirzepatide.

 

​

bottom of page